Ann G. Schwartz

Wayne State University School of Medicine
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (18)

This supplementary table includes the SNPs previously identified in Hung et al. (2021) that were used in the development of our polygenic risk score in non-Hispanic White and African American participants.

Year:

2025

Background: Somatic EGFR mutations define a subset of non–small cell lung cancers (NSCLC) that have clinical impact on NSCLC risk and outcome. However, EGFR -mutation-status is often missing in epidemiologic datasets. We developed and tested pragmatic approaches to account for EGFR -mutation-status based on variables commonly included in epidemiologic datasets and evaluated the clinical utility of these approaches. Methods: Through analysis of the International Lung Cancer Consortium (ILCCO) epidemiologic datasets, we developed a regression model for EGFR -status; we then applied a clinical-restriction approach using the optimal cut-point, and a second epidemiologic, multiple imputation approach to ILCCO survival analyses that did and did not account for EGFR -status. Results: Of 35,356 ILCCO patients with NSCLC, EGFR -mutation-status was available in 4,231 patients. A model regressing known EGFR -mutation-status on clinical and demographic variables achieved a concordance index of 0.75 (95% CI, 0.74–0.77) in the training and 0.77 (95% CI, 0.74–0.79) in the testing dataset. At an optimal cut-point of probability-score = 0.335, sensitivity = 69% and specificity = 72.5% for determining EGFR-wildtype status. In both restriction-based and imputation-based regression analyses of the individual roles of BMI on overall survival of patients with NSCLC, similar results were observed between overall and EGFR -mutation-negative cohort analyses of patients of all ancestries. However, our approach identified some differences: EGFR -mutated Asian patients did not incur a survival benefit from being obese, as observed in EGFR -wildtype Asian patients. Conclusions: We introduce a pragmatic method to evaluate the potential impact of EGFR -status on epidemiological analyses of NSCLC. Impact: The proposed method is generalizable in the common occurrence in which EGFR -status data are missing.

Year:

2025

Background: Financial hardship is most common among cancer survivors with the fewest financial resources at diagnosis; however, little is known about the financial outcomes of young adult (YA) survivors (ages 20–39 at diagnosis), despite their having fewer financial reserves than older adults. Methods: We utilized data from 3,888 participants in the population-based Detroit Research on Cancer Survivors cohort. Participants self-reported several forms of material and behavioral financial hardship (MFH and BFH, respectively). Psychological financial hardship (PFH) was measured using the Comprehensive Score for financial Toxicity (COST) score. Modified Poisson models estimated prevalence ratios (PR) and 95% confidence intervals (CI) for financial hardship by age at diagnosis controlling for demographic, socioeconomic, and cancer-related factors. Results: MFH prevalence was inversely associated with age such that 72% of YA survivors reported MFH, 62% ages 40 to 54, 49% ages 55 to 64, and 33% ages 65 to 79 (PR adjusted YA vs. 65+ : 1.75; 95% CI, 1.49–2.04; P trend adjusted : 1.50; 95% CI, 1.08–2.08; P trend = 0.019). Age was positively associated with financial wellbeing. COST scores ranged from 20.7 (95% CI, 19.0–22.4) among YA survivors to 27.2 (95% CI, 26.1–28.2) among adults 65 to 79 years old ( P trend Conclusions: In this population of African American cancer survivors, MFH and BFH were more common, and PFH was more severe, in YA survivors compared with those diagnosed as older adults. Impact: Young adulthood at diagnosis should be considered a risk factor for cancer-related financial hardship and addressed in work designed to reduce the adverse financial impacts of cancer.

Year:

2025

Background: Racial segregation is linked to poorer neighborhood quality and adverse health conditions among minorities, including worse cancer outcomes. We evaluated relationships between race, neighborhood social disadvantage, and cancer survival. Methods: We calculated overall and cancer-specific survival for 11,367 non-Hispanic Black (NHB) and 29,481 non-Hispanic White (NHW) individuals with breast, colorectal, lung, or prostate cancer using data from the Metropolitan Detroit Cancer Surveillance System. The area deprivation index (ADI) was used to measure social disadvantage at the census block group level, where higher ADI is associated with poorer neighborhood factors. Associations between ADI and survival were estimated using Cox proportional hazards mixed-effects models accounting for geographic grouping and adjusting for demographic and clinical factors. Results: Increasing ADI quintile was associated with increased overall mortality for all four cancer sites in multivariable-adjusted models. Stratified by race, these associations remained among breast (NHW: HR = 1.16, P P P P = 0.00378), prostate (NHW: HR = 1.18, P P P P = 0.00177). Cancer-specific mortality estimates were similar to overall mortality. Adjustment for ADI substantially attenuated the effects of race on mortality for breast [overall proportion attenuated (OPA) = 47%, P P P P P = 0.032; CSPA = 36%, P = 0.018). Conclusions: Area-level socioeconomic disadvantage is related to cancer mortality in a racially diverse population, impacting racial differences in cancer mortality. Impact: Understanding the role of neighborhood quality in cancer survivorship could improve community-based intervention practices.

Year:

2025

Background: Tumor-infiltrating lymphocytes (TIL) confer a survival benefit among patients with ovarian cancer; however, little work has been conducted in racially diverse cohorts. Methods: The current study investigated racial differences in the tumor immune landscape and survival of age- and stage-matched non-Hispanic Black and non-Hispanic White women with high-grade serous ovarian carcinoma (HGSOC) enrolled in two population-based studies ( n = 121 in each racial group). We measured TILs (CD3 + ), cytotoxic T cells (CD3 + CD8 + ), regulatory T cells (CD3 + FoxP3 + ), myeloid cells (CD11b + ), and neutrophils (CD11b + CD15 + ) via multiplex immunofluorescence. Multivariable Cox proportional hazard regression was used to estimate the association between immune cell abundance and survival overall and by race. Results: Overall, higher levels of TILs, cytotoxic T cells, myeloid cells, and neutrophils were associated with better survival in the intratumoral and peritumoral region, irrespective of tissue compartment (tumor, stroma). Improved survival was noted for T-regulatory cells in the peritumoral region and in the stroma of the intratumoral region, but no association for intratumoral T-regulatory cells. Despite similar abundance of immune cells across racial groups, associations with survival among non-Hispanic White women were consistent with the overall findings, but among non-Hispanic Black women, most associations were attenuated and not statistically significant. Conclusions: Our results add to the existing evidence that a robust immune infiltrate confers a survival advantage among women with HGSOC; however, non-Hispanic Black women may not experience the same survival benefit as non-Hispanic White women with HGSOC. Impact: This study contributes to our understanding of the immunoepidemiology of HGSOC in diverse populations.

Year:

2025

Background: Black women with endometrial cancer have twice the mortality compared with White. Survival disparities remain after accounting for individual-level socioeconomic and cancer-related factors. We investigated associations between area-based deprivation and survival and explored whether area-based deprivation attenuates the association between race and survival, among a cohort of Black and White women. Methods: Data from endometrial cancers diagnosed between 2013 and 2022 were collected from a comprehensive cancer registry covering Metropolitan Detroit. Addresses at diagnosis were linked to the area deprivation (ADI) and social vulnerability (SVI) indices. Adjusted Fine and Gray models and Cox proportional hazard models were run investigating associations between area-based deprivation measures and survival; analyses were conducted estimating the proportion of the association between race and survival that was attenuated by area-based measures. Results: Higher deprivation was associated with poorer survival, adjusted for race, insurance status, and tumor characteristics. Compared with the least disadvantaged quartile, the quartile with the highest disadvantage using ADI and SVI had 1.18 [95% confidence interval (CI), 0.99–1.43] and 1.40 (1.14–1.71) times the hazard of endometrial cancer–specific mortality, respectively. ADI and SVI attenuated 18% (3%–38%) and 27% (10%–48%) of associations between race and mortality overall and 24% (95% CI, 3%–61%) and 40% (95% CI, 16%–78%) among those with high-grade histology. Conclusions: This study demonstrates a clear association between neighborhood-level disadvantage and survival among women with endometrial cancer living in Metropolitan Detroit. Neighborhood disadvantage attenuates the relationship between race and survival, particularly among those with high-grade histology. Impact: These findings serve as motivation to understand how neighborhood affects cancer outcomes.

Year:

2025

Table S2 details the hazard ratio for all-cause mortality by neighborhood deprivation quartile for women with endometrial cancer, adjusted for race and insurance status; stratified by histology-grade category

Year:

2025

Geographic distribution of EJI variables in metropolitan Detroit at the census tract level for ( A ) SVM raw scores categorized by quartile, ( B ) EBM raw scores categorized by quartile, and ( C ) combined SER raw scores categorized by quartile. For each variable, Q1 is depicted in light yellow, Q2 in light orange, Q3 in medium orange, and Q4 in dark orange. Raw score values corresponding to each quartile are shown in the legends. Census tracts without sufficient data to calculate scores are shown in black.

Year:

2025

Neighborhood quality affects both socioeconomic factors and exposure to carcinogenic environmental pollutants, but the impacts of these factors on racial disparities in colorectal cancer mortality are not well described. We used the Centers for Disease Control and Prevention Environmental Justice Index social vulnerability module, environmental burden module (EBM), and the combined social–environmental score (SER) to assess relationships with colorectal cancer mortality by race and age in the Metropolitan Detroit Cancer Surveillance System. Among 13,505 patients with colorectal cancer [9,727 non-Hispanic White (NHW) and 3,778 non-Hispanic Black (NHB)], EBM quartile 4 versus 1 was more strongly associated with mortality among NHB early-onset (EO) cases than NHW EO cases [NHB: HR = 1.98, 95% confidence interval (CI), 1.20–3.26; NHW: HR = 1.40, 95% CI, 0.88–2.25]. SER quartile 4 versus 1 was more strongly associated with colorectal cancer mortality in EO (NHB: HR = 1.76, 95% CI, 0.93–3.31; NHW: HR = 1.53, 95% CI, 0.79–2.96) compared with later-onset cases (NHB: HR = 1.15, 95% CI, 0.87–1.52; NHW: HR = 1.39, 95% CI, 1.17–1.65) regardless of race. These associations in EO cases were strongest in colon tumors versus rectal tumors (EO EBM: colon HR = 2.08, 95% CI, 1.24–3.48 vs. rectum HR = 1.03, 95% CI, 0.64–1.66; EO SER: colon HR = 2.57, 95% CI, 1.38–4.79 vs. rectum HR = 0.84, 95% CI, 0.48–1.45). These results suggest the combination of socio-environmental burdens contributes to age and racial disparities in colorectal cancer mortality in metropolitan Detroit. Significance: Understanding the role of environmental justice in cancer survivorship could influence policy decisions, aiding intervention practices.

Year:

2025

Background: The role of adult adiposity in young-onset breast cancer (YOBC) subtype risk is not well understood. Methods: In this population-based case ( n = 1812)–control ( n = 1,381) study of invasive YOBC (ages + , and triple negative (TN)] were calculated, overall and by parity, using multivariable weighted logistic regression. Results: Obese young adult BMI was inversely associated with luminal A YOBC (OR = 0.35, 95% CI, 0.16–0.79); other subtype associations were nonsignificant. Similarly, adult overweight and obese BMIs were inversely associated with luminal A (OR = 0.66, 95% CI, 0.48–0.91 and OR = 0.59, 95% CI, 0.46–0.87, respectively), but not other subtypes. Conversely, larger waist circumference was associated with higher odds of luminal B and TN YOBC (OR = 1.48, 95% CI, 1.01–2.15 and OR = 2.48, 95% CI, 1.52–3.88, respectively), but not other subtypes (with similar results for weight-to-height ratio); highest odds were among parous women. Conclusions: Findings show greater general adult adiposity is associated with reduced odds of luminal A YOBC, whereas greater central adiposity is associated with increased odds of luminal B and TN YOBC, particularly among parous women. Impact: Additional studies of central adiposity and YOBC subtype risk, especially incorporating pregnancy history, are warranted.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (56)

Rayjean Hung

University of Toronto

CANADA
View details

Natalie Snider

Wright State University

UNITED STATES
View details

Susan M. Rosenberg

Ben F Love Chair in Cancer Research and professor

Baylor College of Medicine

UNITED STATES
View details

Greg Dyson

Professor

Wayne State University

UNITED STATES
View details

Patricia Moorman

Professor

Duke University

UNITED STATES
View details

Jun Xia

assistant professor

Texas A&M University

UNITED STATES
View details

Yanhong Liu

Associate Professor

Baylor College of Medicine

UNITED STATES
View details

Edward Peters

Professor and Chair

University of Nebraska College of Public Health

UNITED STATES
View details

Yun-Chul Hong

Seoul National University College of Medicine

SOUTH KOREA
View details

Hirva Mamdani

Karmanos Cancer Institute

UNITED STATES
View details

Sanjay Shete

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Julie Boerner

Associate Professor

Wayne State University

UNITED STATES
View details

David Christiani

Harvard University

UNITED STATES
View details

Adonina Tardon

Coordinating Professor of the Doctoral Program in Medicine and Epidemiology

Universidad Antonio de Nebrija

SPAIN
View details

Christopher I. Amos

Associate Director for Population and Data Science

Baylor College of Medicine

UNITED STATES
View details

Ariel Washington

Assistant Professor

Wayne State University

UNITED STATES
View details

Beata Swiatkowska

Professor

Medical University of Lodz

POLAND
View details

Elena Stoffel

Professor of Internal Medicine

University of Michigan

UNITED STATES
View details

Melinda Aldrich

Vanderbilt University Medical Center

UNITED STATES
View details

Fulvio Lonardo

Wright State University

UNITED STATES
View details

Ayman O. Soubani

Wayne State University School of Medicine

UNITED STATES
View details

Emily Guseman

Assistant Professor

Ohio University Heritage College of Osteopathic Medicine

UNITED STATES
View details

Susan Pinney

University of Cincinnati

UNITED STATES
View details

Stig E. Bojesen

Copenhagen University Hospital

DENMARK
View details

Chao Cheng

Associate Professor

Baylor College of Medicine

UNITED STATES
View details

Diptasri Mandal

Professor (Tenured)

Louisiana State University Health Sciences Center

UNITED STATES
View details

Kristen S. Purrington

Associate Professor

Wayne State University School of Medicine

UNITED STATES
View details

Hallgeir Rui

Professor

Thomas Jefferson University

UNITED STATES
View details

John Field

Professor

University of Liverpool

UNITED KINGDOM
View details

Yohan Bossé

Laval University

CANADA
View details

Alberto Ruano-Ravina

Full Professor

Universidade de Santiago de Compostela

SPAIN
View details

Jose Conejo-Garcia

Duke Science and Technology Scholar

Duke Medicine

UNITED STATES
View details

Michele L. Cote

Indiana University

UNITED STATES
View details

Ryan Sun

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Joan Bailey-Wilson

Co-Branch Chief

National Human Genome Research Institute

UNITED STATES
View details

Philip Lazarus

Professor

University at Buffalo

UNITED STATES
View details

Heather Gibson

Associate Professor (tenured)

Wayne State University

UNITED STATES
View details

Matthew Schabath

Program Leader and Senior Member

H Lee Moffitt Cancer Center and Research Institute

UNITED STATES
View details

Loic Le Marchand

Professor

University of Hawaii

UNITED STATES
View details

Jennifer Anne Doherty

Professor

University of Utah

UNITED STATES
View details

Mikael Johansson

Ass professor

Umea University

SWEDEN
View details

Theresa Hastert

Associate Professor

Wayne State University School of Medicine

UNITED STATES
View details

Michael Peter Alan Davies

Roy Castle Lung Cancer Foundation Senior Research Fellow

University of Liverpool

UNITED KINGDOM
View details

Jian-Rong Li

Assistant Professor

Chang Gung University

TAIWAN
View details

Jinyoung Byun

Associate Professor

University of New Mexico

UNITED STATES
View details

Mattias Johansson

Scientist

International Agency for Research on Cancer

FRANCE
View details

Mike Wilson

Assistant Professor

Wayne State University

UNITED STATES
View details

Susanne Arnold

University of Kentucky

UNITED STATES
View details

Geoffrey Liu

The M. Qasim Choksi Chair in Lung Cancer Translational Research

University of Toronto

CANADA
View details

Ping Yang

Professor

Mayo Clinic Arizona

UNITED STATES
View details

Elisa Bandera

Chief

Rutgers Cancer Institute of New Jersey

UNITED STATES
View details

Chu Chen

Full Member

Fred Hutchinson Cancer Research Center

UNITED STATES
View details

Jamaica Robinson

Assistant Professor

Wayne State University School of Medicine

UNITED STATES
View details

Rui Manuel Reis

-

PORTUGAL
View details

Carina Gronlund

University of Michigan

UNITED STATES
View details

Kelly Hirko

Michigan State University

UNITED STATES
View details